{"nct_id":"NCT01582997","title":"A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2012-05-11","start_date_type":"ACTUAL","primary_completion_date":"2014-08-01","primary_completion_date_type":"ACTUAL","completion_date":"2015-04-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}